Orexo
Orexo: Zubsolv Rx data and estimate update (Redeye)
2019-01-18 14:24
According to the latest prescription data from Symphony Health Solutions, which was released today, the market share (R4W) of Zubsolv amounts to 4.7% (prescriptions) and 5.2% (quantity). Zubsolv sales continue to grow better than double-digit percentage points (+19% y/y).
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se